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SvSXP: a Strongylus vulgaris antigen with potential
for prepatent diagnosis
Ulla V Andersen1*, Daniel K Howe2, Sriveny Dangoudoubiyam2, Nils Toft1, Craig R Reinemeyer3, Eugene T Lyons2,
Susanne N Olsen1, Jesper Monrad4, Peter Nejsum4 and Martin K Nielsen2

Abstract
Background: Strongyle parasites are ubiquitous in grazing horses. Strongylus vulgaris, the most pathogenic of the
large strongyles, is known for its extensive migration in the mesenteric arterial system. The lifecycle of S. vulgaris is
characterised by a long prepatent period where the migrating larvae are virtually undetectable as there currently is
no test available for diagnosing prepatent S. vulgaris infection. Presence of S. vulgaris larvae in the arterial system
causes endarteritis and thrombosis with a risk of non-strangulating intestinal infarctions. Emergence of anthelmintic
resistance among cyathostomins has led to recommendations of reduced treatment intensity by targeting horses
that exceed a predetermined strongyle faecal egg count threshold. One study suggests an apparent increase in
prevalence of S. vulgaris on farms where reduced anthelmintic treatment intensity has been implemented. These
issues highlight the need for an accurate and reliable assay for diagnosing prepatent S. vulgaris infection.
Methods: Immunoscreening of a larval S. vulgaris cDNA library using hyperimmune serum raised against S. vulgaris
excretory/secretory antigens was performed to identify potential diagnostic antigens. Immunoreactive clones were
sequenced, one potential antigen was characterised, expressed as a recombinant protein, initially evaluated by
western blot (WB) analysis, the diagnostic potential of the IgG subclasses was evaluated by ELISA, and the
diagnostic accuracy evaluated using serum from 102 horses with known S. vulgaris infection status.
Results: The clone expressing the potential antigen encoded a S. vulgaris SXP/RAL2 homologue. The recombinant
protein, rSvSXP, was shown to be a potential diagnostic antigen by WB analysis, and a target of serum IgGa, IgG(T)
and total IgG in naturally infected horses, with IgG(T) antibodies being the most reliable indicator of S. vulgaris
infection in horses. Evaluation of diagnostic accuracy of the ELISA resulted in a sensitivity of 73.3%, a specificity of
81.0%, a diagnostic odds ratio of 11.69; a positive likelihood ratio (LR) of 3.85 and a negative LR was 0.33. The area
under the ROC curve was 0.820.
Conclusion: IgG(T) antibodies to recombinant SvSXP show potential for use as an antigen for prepatent diagnosis
of migrating stages of S. vulgaris with moderate to good diagnostic accuracy.
Keywords: SXP, IgG(T), Strongylus vulgaris, Prepatent, Diagnosis, cDNA library, ELISA, Validation

Background
Strongyle parasites are ubiquitous in grazing horses with
more than 50 different species described [1]. The most
pathogenic of the equine gastrointestinal parasites is
Strongylus vulgaris. The prepatent period of S. vulgaris
is 6–7 months [2], and during this time, the larvae
migrate in the Cranial Mesenteric Artery (CMA) and
* Correspondence: ullava@gmail.com
1
Department of Large Animal Science, Faculty of Health and Medical
Sciences, University of Copenhagen, Copenhagen, Denmark
Full list of author information is available at the end of the article

major branches [3,4]. Here, the larvae cause verminous
endarteritis [5-7], and subsequent thromboembolism
can cause a painful non-strangulating infarction of the
intestinal tract [3,8].
Prior to the advent of modern paste-based dewormers,
S. vulgaris was present in about 80–100% of horses
[9,10], but frequent interval-dose anthelmintic regimens
appear to have caused a dramatic reduction in prevalence
[11,12]. However, these frequent treatments have led to
anthelmintic resistance in other parasite categories infecting
horses; cyathostomins [13-15] and Parascaris equorum
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[16-18], and recommendations are now given to reduce
treatment intensity by basing control programs on
systematic parasite surveillance [19-21]. In the European
Union, prescription-only restrictions on anthelmintic drugs
have been or are being implemented by legislation of
member countries [22]. Experiences with prescription-only
restrictions in Denmark show that a reduction in treatment
intensity follows [23]. A recent study performed in this
country suggested that these anthelmintic treatment
policies may have contributed to a higher prevalence of S.
vulgaris [24]. Given the high pathogenicity of this parasite,
there is a need for improved diagnostic assays to better
diagnose and monitor this parasite while maintaining
anthelmintic efficacy in equine populations.
Currently, diagnosis of S. vulgaris infection is based on
the presence of eggs shed in faeces of infected horses,
and is accomplished by either larval culture and subsequent microscopic examination [25,26] or by a semiquantitative PCR detecting DNA extracted from the eggs
[27]. So far, no test has been developed to accurately
diagnose the presence of migrating larvae in the CMA
and branches [Reviewed by [28]].
Several attempts have been made to develop a serological test for the diagnosis of prepatent S. vulgaris infection. In the last three decades, whole worm extracts,
surface antigen extracts and excretory/secretory (ES) antigens have been evaluated for use in diagnostic assays
[29-33]. Wynne and co-workers [29] evaluated different
tissue extracts and ES antigens by use of hyperimmune
rabbit sera raised against the different antigenic fractions. This led to the discovery of two species-specific
and one stage-specific ES antigen, but these were not
evaluated with serum from horses naturally or experimentally infected with S. vulgaris. Thus the full diagnostic potential of these antigens remains unknown. Klei
et al. [30] evaluated the unspecific antibody response in
previously helminth-naïve foals that were experimentally
infected with S. vulgaris. These workers developed an
indirect fluorescent antibody (IFA) assay and discovered
that these foals developed a species-specific response
to S. vulgaris L3-larvae with no cross-reactivity with S.
edentatus, S. equinus, or cyathostomins. However,
evaluation of hyperimmune rabbit sera raised against
S. edentatus and S. equinus antigens showed that these
cross-reacted with S. vulgaris larvae; in fact both sera
reacted more strongly against S. vulgaris larvae than S.
edentatus or S. equinus larvae. Therefore, the IFA was
never validated as a diagnostic test. Nichol and
Masterson [31] evaluated S. vulgaris surface antigen
extracts and found them to show a high degree of
cross-reactivity with the closely related S. edentatus
and the more distantly related Parascaris equorum.
Affinity chromatography was performed to remove
cross-reactive antibodies from the hyperimmune rabbit
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serum and three antigens were found to be potential
diagnostic antigens. Adeyefa [32] evaluated somatic extracts
using the IgG(T) fraction of serum from horses naturally
infected with gastrointestinal helminths including arterial S.
vulgaris larvae and found two potential diagnostic antigens.
Cross-reactivity with other gastrointestinal helminths was,
however, not assessed. Hassan et al. [33] recently evaluated
adult somatic antigen and found the ELISA to detect more
positive samples than the larval culture. No horses were
necropsied for determination of true infection status, and
ELISA results were only compared to larval cultures, so
diagnostic performance cannot be assessed [33]. Taken
together, none of the potential antigens described here
were fully evaluated or validated as diagnostic tests,
and most of them were not fully characterized. The
antigens discovered by Nichol and Masterson [31]
were the only antigens to be isolated and expressed
in vitro [31], but sera from naturally infected horses
failed to recognise these. No attempt has been made to
clone the S. vulgaris antigen or express recombinantly
for incorporation into a diagnostic test.
Recently, a molecular approach was employed for
identifying candidate molecules for prepatent diagnosis
of another important parasite group infecting horses;
larval cyathostomins. This included immunoscreening of
a cDNA library constructed from encysted cyathostomin
larvae and allowed identification of a promising antigen
to be evaluated as a candidate for diagnosing encysted
cyathostomin larvae [34]. This protein was found to be
stage-specific as it is only expressed in the larval stages
of the cyathostomins.
This study employed immunoscreening of a S. vulgaris
larval cDNA library to identify genes that encode potential
diagnostic antigens. The aims were to subsequently explore
the use of these in immunodiagnostic assays for a diagnosis
of prepatent S. vulgaris infection, to evaluate the inter- and
intra-assay variability, the diagnostic properties, as well as
the quantitative aspects of the assay.

Methods
Horses

A total of 102 horses with necropsy-confirmed status of
S. vulgaris infection were enrolled in the validation
study. All necropsies were performed at either University
of Kentucky in Lexington, Kentucky or East Tennessee
Clinical Research (ETCR) in Rockwood, Tennessee.
All horses from University of Kentucky were naturally
infected with mixed species of gastrointestinal helminth infections (n=31). They were enrolled from two main populations; a herd kept without anthelmintic intervention since
1979 [35], and a population of research horses maintained
with four anthelmintic treatments a year. Naturally
infected horses from Tennessee (n=23) participated in different anthelmintic drug trials at ETCR and all underwent
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necropsy. In total, samples from 54 naturally infected
horses were collected.
Experimental infections were carried out for two
different research projects with horses maintained at
ECTR (n=48). Horses in group P (n=20) were treated
once daily for five consecutive days with fenbendazole
paste (10 mg/kg, Panacur, Merck, Summit, NJ, USA),
housed in stables and inoculated on a single occasion
with 600 embryonated P. equorum eggs obtained locally
from naturally infected horses. After six months the
horses were euthanatised and necropsied. Horses in
group S (n=28) were acquired with unknown anthelmintic
treatment history, and were therefore treated with a larvicidal regimen of moxidectin (0.4 μg/kg, Quest gel, Pfizer,
Madison, NJ, USA) administered once, and fenbendazole
paste (10 mg/kg, Panacur) once daily for five consecutive
days during the week prior to enrolment in the study.
They were subsequently infected with 5,000 cyathostomin
third stage larvae (L3) five times weekly throughout the
study. Five weeks into the study the horses started receiving 25 S. vulgaris L3 larvae once weekly until euthanasia
and necropsy after 5.5 months [36].
At necropsy, the posterior aorta and cranial mesenteric
artery and branches were recovered and evaluated for
the presence of migrating S. vulgaris larvae in all horses.
The case-definition that served as the gold standard
for classification of S. vulgaris positive horses was:
horses with migratory tracts, one or more larvae, or evidence of previous infection. Migratory tracts were considered evidence of a current infection, and a circular
area with raised surface, roughened or corrugated intima
without evidence of active thrombosis was classified as
evidence of previous infection. Horses with no migratory
tracts, no larvae, and no signs of previous infection were
classified as being S. vulgaris-negative.
The gastrointestinal and migrating parasites were
enumerated as previously described [37].
A peripheral blood sample was collected from each
horse (n=102) in a serum or serum-separator tube. Sera
were separated by centrifugation, and duplicate aliquots
were transferred to 2 mL cryovials and stored at −20°C
until analysis. The serum was stored for up to 5 years
prior to analysis.
The horses in this study had a mean age of 19.5 months (range 0.6 months – 22 years) with a median of
12 months of age. A total of 46 horses were female and
54 were males of which 12 were castrated. Data on age
and gender was missing for two and one horse, respectively. The subset of horses 7 months and older had a
mean age of 22.51 months (range 7 months – 22 years)
with a median of 18 months of age with 44 female, 42
males of which 12 were castrated. Data from horses 3 months and younger were omitted; the next youngest
foal was 7 months old. Breeds represented included:
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Tennessee Walking Horse, Paint, American Quarter
Horse, Thoroughbred, Standardbred, Appaloosa, Shetland
type ponies and mixed light breed.
All work involving the horses at UK and ETCR was
approved by the Institutional Animal Care and Use
Committee.
Parasite material

Migrating S. vulgaris larvae were collected by dissection
of the abdominal aorta, celiac artery, cranial mesenteric
artery and major branches recovered from horses at the
University of Kentucky that were naturally infected with
gastrointestinal parasites and where anthelmintic drugs
have not been used since 1979 [35]. The larvae were
carefully lifted from the thrombus material and washed
four times in 20 mL PBS (137 mM NaCl, 10 mM
phosphate, 2.7 mM KCl, pH 7.4) to remove debris.
The larvae were either placed in 2 mL cryotubes and
snap frozen in liquid N2 for RNA extraction or used
for collection of ES antigens.
Worms were collected from the caeca of horses using
the necropsy technique previously described [37], adult
S. vulgaris worms were identified by morphological criteria [1] and washed five times in 20 mL PBS to remove
debris and used for collection of ES antigens.
Excretory/secretory antigens

Living washed adult worms were incubated in 5 mL
RPMI-1640 (Life Technologies, Grand Island, NY, USA)
with penicillin (100 IU/mL), streptomycin (100 IU/mL),
amphotericin B (0.25 μg/mL) and a protease inhibitor
cocktail (Protease inhibitor cocktail, P2714, SigmaAldrich, St. Louis, MO, USA) in a 5% CO2 incubator at
37°C. The medium was collected after 12 and 24 h and
fresh medium was added. The protein concentration was
analysed using the Bradford Protein quantitation assay
(Pierce, Rockford, IL, USA) as per the manufacturer’s
protocol. The ES antigen-rich medium was then dialysed
against PBS at 4°C using a 3 mL 3.5 kDa molecular cutoff Slide-A-LyzerW (Pierce, Rockford, IL, USA) according
to the manufacturer’s protocol. Dialysed ES antigen
was frozen and shipped to Cocalico Biologicals, Inc.
(Reamstown, PA, USA) for production of hyperimmune
serum. One rat was immunised with 250 μg adult S.
vulgaris ES antigen mixed with TitermaxW as adjuvant and
given as six inoculations over a 61-day period. Due to background reactivity against E. coli proteins, the hyperimmune
rat serum was pre-absorbed extensively against E. coli
XL1-BLUE lysates [38].
Larval ES antigens were obtained from S. vulgaris larvae
using 2 mL of RPMI-1640 (Life Technologies, Grand
Island, NY, USA) with penicillin (100 IU/mL), streptomycin (100 IU/mL), amphotericin B (0.25 μg/mL) and
a protease inhibitor cocktail (Protease inhibitor cocktail,
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P2714, Sigma-Aldrich, St. Louis, MO, USA) and incubating
the larvae in a 5% CO2 incubator at 37°C. The medium was
collected after 14 days during which time the dead larvae
were removed daily with a sterile needle.
A total of 300 ng of S. vulgaris larval ES antigens was adjusted to 15 μL with water and mixed with 3 μL 5X sodium
dodecyl sulphate-polyacrylamide gel electrophoresis (SDSPAGE) sample buffer containing protease inhibitor cocktail.
The same amount of S. vulgaris adult ES was prepared
similarly. The ES mixtures were denatured at 95°C for
5 min, placed on ice for 5 min and resolved in individual
wells under reducing conditions in a 12% polyacrylamide
gel, where after the gel was stained by silver staining.
Construction and immunoscreening of a larval S. vulgaris
cDNA library

RNA was extracted from N2 frozen S. vulgaris larvae
using the Trizol reagent (Life Technologies, Grand
Island, NY, USA) and poly(A)+ RNA (mRNA) was purified from total RNA using the NucleoTrapW mRNA-kit
(Clontech, Mountain View, CA, USA) according to the
manufacturer's protocol. A total of 400 ng purified
mRNA was used as template to synthesise cDNA using
the SMART cDNA library construction kit (Clontech,
Mountain View, CA, USA), cloned into bacteriophage
TriplEx2 lambda vector digested with NdeI and packaged
using the Giga Pack III gold packaging extract (Agilent
Technologies, Stratagene products division, La Jolla, CA,
USA) as previously described for a larval cyathostomin
cDNA library [34]. The titre of the cDNA library was
evaluated and the quality was assessed by analysing cDNA
inserts in 30 randomly-picked plaques by PCR analysis.
The PCR products were cleaned using the WizardW SV Gel
and PCR clean-up system (Promega, Madison, WI, USA)
and sequenced at the University of Kentucky’s Advanced
Genetic Technology Center.
The S. vulgaris larval cDNA library was immunoscreened
as described by the manufacturer (Clontech, Mountain
View, CA, USA). The primary immunoscreening was
conducted on 100,000 cDNA clones. Plaque lifts were made
onto nitrocellulose membranes (Fisher Scientific, Pittsburg,
PA, USA) and the membranes were washed five times for
5 min in 25 mL TBST (100 mM Tris, 0.15 M NaCl and
0.05% Tween-20) and kept in TBST overnight at 4°C. The
membranes were blocked with TBST + 1% gelatine for 1 h
at room temperature (RT) and probed with preabsorbed
hyperimmune rat serum at 1:100 in TBST after washing. As
secondary antibodies, horseradish peroxidase (HRP)-conjugated goat anti-rat IgG (H+L) (Jackson ImmunoResearch,
Inc. West Grove, PA, USA) were used at 1:10,000 in
TBST after washing. The signal was developed using a
chromogenic substrate (TMB stabilised substrate for
HRP, Promega, Madison, WI, USA) after washing. The
membranes were aligned with the agar plate, and the
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positive clones were picked using p200 pipette tips.
The selected plaque was placed in 500 μL Lambda
dilution buffer (0.1 M NaCl, 10 mM MgSO4, 3.5 mM
Tris and 0.01% gelatin), vortexed for 30 s and kept at 4°C.
The positive clones underwent secondary immunoscreening
with the hyperimmune rat serum and rat-pre-immunisation
serum as negative control to exclude false positive clones.
Sequence analyses

Clones isolated from the cDNA library were amplified
by PCR using vector-specific primers and sequenced at the
University of Kentucky’s Advanced Genetic Technology
Center. The resulting sequences were used as queries in
BLASTN searches against non-human, non-mouse nucleotide sequences and BLASTX searches against the nonredundant protein database from NCBI. The presence of a
signal peptide was predicted using SignalP 4.0 [39], the
presence of glycosylation sites were analysed using the
ExPASy Prosite [40] and the presence of transmembrane
domains and protein localisation were predicted using
TMHMM 2.0 server [41]. Pairwise alignment and phylogenetic comparison was performed using the ClustalOmega
software on the EBI-server [42]. Homologues from
Cylicostephanus goldi (courtesy of Dr. Jane Hodgkinson,
University of Liverpool) and P. equorum (courtesy of Dr.
Georg von Samson-Himmelstjerna, University of Berlin)
were obtained and the partial sequences compared by
pairwise alignment using the ClustalOmega software.
Expression of recombinant protein

Primers were designed to amplify the coding sequence
from an immune-reactive cDNA clone for subcloning into
a pET22b(+) vector. The primer sequences were as follows:
Forward: 5’-GATCCATATGCAAAATGGACCTCCACC-3'
and reverse: 5'-GATCCTCGAGTCCCTTCATAGCGTCC3' which incorporated the NdeI and XhoI restriction sites
(underlined) to allow for unidirectional cloning. The PCR
was performed using Verbatim High Fidelity Polymerase
(Thermo Fisher Scientific, Pittsburg, PA, USA) and the
amplified fragment was digested with NdeI and XhoI and
ligated with the pET22b(+) plasmid. The resulting plasmid
was transformed into E. coli BL21 cells and expression of
the recombinant protein was induced by 1 mM isopropyl-β
-D-thiogalactopyranoside (IPTG) at an OD600nm of 0.6 and
the cells were incubated under agitation for 9 h at 30°C.
The recombinant protein was purified on immobilised cobalt by affinity chromatography using BD TALON resin
(Clontech, Mountain View, CA, USA) as per the manufacturer’s protocol for soluble proteins. Purified recombinant
protein was stored in aliquots at −20°C.
Hyperimmune serum against recombinant protein

A total of 300 μg of recombinant protein was resolved in
12% polyacrylamide gels under reducing conditions, a
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strip of the gel was stained with GelCode Blue stain
(Thermo Scientific, Pittsburg, PA, USA) to verify where the
recombinant antigen travelled in the gel and the corresponding part of the gel containing the desired molecular
size was cut out and shipped to Cocalico Biologicals, Inc.
(Reamstown, PA, USA) and used to immunise a guinea pig
with Freund’s complete adjuvant for initial immunisation
and Freund’s incomplete adjuvant for subsequent boosters.
The guinea pig was immunised by 6 inoculations of recombinant antigen over a period of 17 weeks.
Western blot analyses
S. vulgaris ES

For Western blot (WB) analysis of anti-adult S. vulgaris ES
rat serum against both S. vulgaris larval and adult ES antigens, the antigens were mixed individually with SDS-PAGE
sample buffer containing protein inhibitor cocktail under
reducing conditions and resolved in two 1-well 12% polyacrylamide gels. The proteins were transferred to 0.45 μm
nitrocellulose membranes by semidry electrophoretic transfer in Tris-glycine buffer. Membranes were blocked for 1 h
in PBST (PBS + 0.05% Tween-20), and probed with preimmunisation rat serum at 1:100 in PBST or hyperimmune
rat serum raised against S. vulgaris adult ES at 1:100 in
PBST. The signal was developed using TMB stabilised substrate for HRP (Promega, Madison, WI, USA).
For WB analysis of anti-recombinant protein guinea
pig serum against larval ES, 4.4 μg S. vulgaris larval ES was
resolved in a 1-well 12% polyacrylamide gels, transferred to
a nitrocellulose membrane and blocked. The nitrocellulose
membrane was cut and strips were placed in individual
trays. The strips were probed with either 500 μL of guinea
pig pre-immunisation serum at 1:500 in PBST or guinea
pig hyperimmune serum anti-recombinant protein at
1:2,500 in PBST. HRP-conjugated goat anti-horse IgG(T)
(Bethyl Laboratories, Inc., Montgomery, TX, USA), were
used as secondary antibodies at 1:10,000 in PBST. The
signal was developed using Supersignal WestPico chemiluminescent substrate (Pierce, Rockford, IL, USA).
Recombinant protein

Recombinant protein (233 ng) was resolved in each of two
1-well 12% polyacrylamide gels by SDS-PAGE under
reducing conditions and transferred to nitrocellulose membranes. The membranes were blocked and one was placed
in a multi-slot apparatus (Bio Rad, Hercules, CA, USA).
The blot was probed with 500 μL horse serum samples
(1:50 in PBST) in each slot. As secondary antibodies, HRPconjugated goat anti-horse IgG(T) (Bethyl Laboratories,
Inc., Montgomery, TX, USA), were used at 1:10,000 in
PBST. The signal was developed using Supersignal
WestPico chemiluminescent substrate.
Strips were cut from the other blocked blot and placed
in individual trays. The strips were probed with either
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pre-immunisation guinea pig serum at 1:500 in PBST or
anti-recombinant protein guinea pig serum at 1:2500 in
PBST. As secondary antibody, HRP-conjugated donkey
anti-guinea pig IgG (H+L) (Jackson ImmunoResearch,
Inc., West Grove, PA, USA) were used at 1:10,000 in
PBST. The signal was developed using Supersignal
WestPico chemiluminescent substrate.
ELISA

The indirect ELISA was optimised by sequential
checkerboard titration to the following setup. Individual
wells of a 96 well EIA/RIA plate (CostarW easy-wash,
Corning Inc., Corning, NY, USA) were coated with 75
μL of recombinant protein diluted to 0.1 μg/mL in PBS
and incubated overnight at 4°C. The wells were washed
three times for 1 min with PBST and blocked for 1½ h at
RT with 200 μL block solution (PBS containing 5% normal
goat serum, 1% dry milk powder and 1% Tween-20). The
wells were washed once and 75 μL of horse serum diluted
1:50 in diluent solution (block solution in PBST, 1:10) was
added to individual wells in duplicates and incubated for
1 h at 37°C. Positive, negative and blank controls were included on each plate in duplicates. The wells were washed
five times with PBST, and 75 μL of HRP-conjugated goat
anti-horse IgG (H+L) (Jackson ImmunoResearch, Inc.
West Grove, PA, USA) diluted 1:10,000 was added to each
well and incubated for 1 h at 37°C. The wells were washed
five times with PBST and incubated for 10 min at RT in
the dark with 75 μL of RT 1-step Ultra TMB ELISA substrate (Thermo Scientific, Rockford, IL, USA) per well.
The reactions were stopped with 75 μL 2 M H2SO4 per
well, and the OD450nm determined using an E-max Precision Microplate Reader (Molecular Devices, Sunnyvale,
CA, USA) with a photometric range of 0.000 to 4.000 OD
and a resolution of 0.001 OD.
IgG subclass antibodies

For evaluation of the optimal diagnostic antibody target
in serum from 15 horses with known S. vulgaris larval
infection status, the level of antigen specific IgG subclasses IgGa, IgGb, IgGc and IgG(T) were evaluated using
HRP-conjugated goat anti-horse IgGa, IgGb, IgGc and
IgG(T) antibodies (Bethyl Laboratories, Inc., Montgomery,
TX, USA) at 1:40,000 as secondary antibodies as per the
manufacturer’s recommendation alongside the HRPconjugated goat anti-horse IgG (H+L) secondary antibody
as described in the ELISA setup.
After identifying the best antibody target, the secondary
antibody dilution for the ELISA was optimised by checkerboard titration.
Diagnostic accuracy of ELISA

These ELISAs were performed in June and July, 2012.
Serum samples from all horses (n=102) and horses seven
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months and older (n=86) were evaluated for the level of
antigen specific IgG and IgG(T) antibodies using the
optimised ELISA in separate assays. The intra-assay
variability of the ELISA was calculated from duplicate
measurements from all horses. The inter-assay variability
was calculated from the positive and negative controls
included in each assay as well as specifically for three
horses that were selected on the basis of their rSvSXPspecific IgG(T) OD450nm (OD value given in parentheses).
These animals served as a high positive (2.708), an intermediate positive (1.278) and a negative (0.022). From each
sample, a volume of 1,000 μL of serum diluted 1:50 in diluent solution was prepared to test triplicate samples on each
of four sequential days to evaluate inter-assay variability as
a normalised value, percentage of a positive control (PP), as
previously described [43].
Statistical analyses

The statistical program R, version 2.12 [44] was used to
generate graphs and perform statistical analyses. For all
statistical analyses, a P-value less than or equal to 0.05
was considered significant.
Evaluation of IgG subclasses

The non-parametric Wilcoxon rank sum test was used
to compare IgG levels within each IgG subclass between
S. vulgaris infected and uninfected horses.
Intra- and inter-assay variability

The intra- and inter-assay % coefficient of variability
(% CV) was calculated for each series of assays for each
of the secondary antibodies. An intra-assay % CV below
10% and an inter-assay % CV below 20% were considered
acceptable [45].
Receiver operator characteristics (ROC) curve analysis

ROC curve analyses were performed using the software
package Epi for R [46] for two sets of horses: all horses
(n=102) and horses seven months or older (n=86). The
reason for excluding foals in the second analysis was due
to observations of high larval counts and corresponding
low PP-values in some of the younger foals. After excluding horses younger than three months of age the
remaining horses were all seven months or older. The
optimal cut-off was determined on the basis of the ROC
curve analysis.
Diagnostic accuracy

For the two sets of horses: all horses and horses 7 months
and older, the software package EpiR for R [47] was
used to calculate the diagnostic accuracy values; sensitivity, specificity, odds ratio, positive likelihood ratio
(LR) and negative LR with corresponding 95% confidence intervals.
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Correlation of arterial S. vulgaris larvae and rSvSXP-specific
antibodies

The correlation between the number of S. vulgaris larvae
in the cranial mesenteric artery and branches and the
level of rSvSXP specific IgG(T)-antibodies expressed as the
normalised PP-value was evaluated by the Spearman correlation test from the software package fBasics for R [48].
All horses (n=102) were categorised by the number of
larvae present in the CMA and branches in the following
five groups: Group 0: No larvae, migratory tracts or evidence of previous infection (n=42); group 1: No larvae, but
migratory tracts or evidence of previous infection (n=16);
group 2: 1–5 larvae (n=16); group 3: 6–25 larvae (n=17);
and group 4: above 25 larvae (range: 25–292) (n=11).
A subset of the horses, horses 7 months or older
(n=86), was categorised by the number of S. vulgaris
larvae in the CMA and branches in the following five
groups: Group 0: No larvae, migratory tracts or evidence
of previous infection (n=28); group 1: Migratory tracts
or evidence of previous infection (n=16); group 2: 1–5
larvae (n=16); group 3: 6–25 larvae (n=17); and group 4:
above 25 larvae (range: 25–200) (n=9).
The relationship between the different groups and the
PP values was evaluated graphically for both sets of
horses. A Kruskal-Wallis test was performed to evaluate
if there was a significant difference between groups and a
multiple comparison test after Kruskal-Wallis performed
to identify the significantly different groups using the
statistical software package pgirmess for R [42]. This was
performed on both sets of horses.

Results
Preliminary characterisation of ES and rat anti-ES serum

The silver staining of the polyacrylamide gel showed a
highly diverse mixture of molecules in both S. vulgaris
larval and adult ES (Figure 1). The hyperimmune rat
serum that was raised against S. vulgaris adult ES
recognised more molecules in the adult ES than it did in
the larval ES (Figure 1).
cDNA library and immunoscreening

Titre analysis indicated that the primary unamplified cDNA
library contained 4.75x106 plaque forming units (pfu)/mL.
Thirty plaques were randomly selected from the library,
and PCR analysis showed that 28 of the clones had inserts
(93.3%) and that 26 of the 28 (92.9%) had inserts larger than
or equal to 500 bp. Based on BLASTx searches, sequence
analysis of the 26 large-insert clones from the quality
assessment indicated that they all coded for different gene
products (data not shown). Horse serum from naturally
infected horses was initially used for immunoscreening of
the cDNA library; however, strong levels of anti-E. coli antibodies in the horse serum resulted in high background
staining that could not be controlled (data not shown).
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amino acid sequence similarity with a partial sequence
from the Cylicostephanus goldi homologue, followed
by the surface-associated antigen 2 (SAA-2) from
Necator americanus [Genbank: ACE79378.1], and thirdly
the immunodominant-hypodermal antigen AC16 from
Ancylostoma caninum [Genbank: ABD98404.1]. Two
partial sequences from a P. equorum derived homologue
had a lesser degree of similarity (35% and 46% identities)
(Figure 2a). Proteins of SXP-group contain a domain of unknown function (DUF148). The phylogenetic comparison
clustered C. goldi with S. vulgaris, P. equorum with Ascaris
suum and N. americanus with A. caninum (Figure 2b).
Analysis of SvSXP in S. vulgaris larval ES

Western blot analyses of rSvSXP and larval ES using
hyperimmune guinea pig anti-rSvSXP serum showed
that the hyperimmune serum recognised a molecule of
similar size in both blots. The pre-immunisation guinea
pig serum did not react against the 14 kDa recombinant
antigen (Figure 3).

Figure 1 Silver stained gel. Lanes A+B illustrate that Strongylus
vulgaris larval and adult excretory/secretory (ES) fractions contain a
highly diverse mixture of molecules. Lane A: larval ES, lane B: adult
ES – both stained by silver staining. To the left the low range
molecular markers are shown. Western blot analysis: Lane
C: reactivity of pre-immunisation rat serum against larval ES; lane
D: reactivity of anti-adult S. vulgaris ES probed against larval ES; lane
E: anti-adult S. vulgaris ES probed against adult ES; and lane
F: reactivity of anti-adult S. vulgaris ES against larval ES. Preimmunisation serum did not recognise molecules in either ES
fraction (lanes C and F), and the hyperimmune serum recognised
more molecules in adult ES (lane E) than in larval ES (lane D). To the
right the low range molecular markers are shown.

Western blot analyses of IgG antibodies against rSvSXP in
S. vulgaris-positive and negative horses

The immunodiagnostic potential of antigen-specific IgG
and IgG(T) antibodies against rSvSXP were evaluated by
WB. These analyses revealed no IgG reactivity to rSvSXP
in serum from two horses not infected with S. vulgaris
(data not shown) and low level IgG(T) reactivity to
rSvSXP in serum from eight horses not infected with S.
vulgaris (Figure 4), as determined by post-mortem
examination. In contrast, serum from seven horses
infected with S. vulgaris showed a strong reaction to
rSvSXP (Figure 4).
Diagnostic potential of IgG subclass antibodies

The primary immunoscreening of 100,000 clones in
the unamplified larval S. vulgaris cDNA library yielded
28 positive clones, all of which confirmed positive on
secondary immunoscreening. The PCR products of these
were all of comparable size (~ 650–680 bp, data not
shown) and sequence results of eight slightly different
sized clones confirmed that their cDNAs coded for the
same protein. The sequence encodes 146 amino acids
including a predicted signal peptide (18 amino acids),
giving rise to a mature peptide of 128 amino acids with an
estimated molecular weight of 13.57 kDa. No glycosylation
sites were predicted and the protein did not have any predicted transmembrane domains. The predicted translation
showed that the encoded protein is homologous to the
SXP/RAL-2 group of nematode specific proteins that contain a conserved Serine-X-Proline motif giving rise to the
name. The protein was designated SvSXP. One sequence
represented a full-length cDNA coding sequence, which
was deposited [GenBank: KC155360]. SvSXP had highest

Analysis of rSvSXP-specific IgG subclasses by ELISA
showed that detection of rSvSXP-specific IgG(T) antibodies gave the clearest distinction between the seven S.
vulgaris positive horses and the eight S. vulgaris negative
horses, while the other IgG subclasses were less consistent (Figure 5). Both the IgG subclasses IgGa (P= 0.016)
and IgG(T) (P=0.016) as well as total IgG (P=0.032)
showed statistically significant differences between infected
and non-infected horses (n=15), whereas IgGb and
IgGc did not.
Inter- and intra-assay coefficients of variability

The intra-assay variability of the ELISA measuring
rSvSXP-specific IgG(T) antibodies was 9.17% for all the
duplicate measurements.
For the IgG(T) assays that were included in this study
the inter-assay % CV for the positive control was 16.9%
while the inter-assay % CV for the negative control was
72.6% resulting in an overall inter-assay % CV of 44.8%.
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Figure 2 Sequence comparison by pairwise alignment and a phylogenetic tree. a) ClustalOmega pairwise alignment of Strongylus vulgaris
SXP (SvSXP) with homologues in other species. SvSXP (accession number: KC155360) is compared with Cylicostephanus goldi SXP partial
homologue, Necator americanus surface-associated antigen (Na-SAA) (ACE79378.1), Ancylostoma caninum immunodominant hypodermal antigen
(Ac16) (ABD98404.1), Ascaris suum 14 kDa antigen (As14) (BAB67769.1), Ascaris lumbricoides antigen 1(Ag1) (ADB45853.1) and Parascaris equorum
partial homologue. The signal peptide for each sequence is underlined. Asterisks (*) denote identical amino acids, double dots (:) denote
conserved amino acid changes and a single dot (.) denotes semi-conserved amino acid changes. Hyphen (−) indicates that a space was inserted
in the sequence to improve alignment. The percent similarity to SvSxP is listed for each homologous protein. b) Phylogenetic tree of the above
mentioned sequences.

When using the PP-value, the overall inter-assay % CV
dropped to 15.6%. The overall inter-assay % CV for the
IgG assays, all measured on the same day, was 11.8%.
Summary of horse material used for evaluation of
diagnostic values of the ELISA

The prevalence of arterial lesions as well as the seroprevalence in each group of horses described under Materials
and Methods is shown in Table 1.
A total of 42 horses showed no signs of migrating larvae
in the CMA and branches or signs of previous infection
and were classified as S. vulgaris-negative, larvae with
migratory tracts and evidence of thrombosis were found
in 47 horses, and migratory tracts or healing lesions were
found in 19 horses, of these 10 were determined to show
evidence of a previous infection.
In the subset of horses seven months or older, 29 were
classified as S. vulgaris-negative with no sign of current
or previous infection; 42 horses had migrating larvae,
migratory tracts and evidence of thrombosis; 17 horses
had migratory tracts or healing lesions but no larvae, of

these seven were determined to show evidence of a previous infection. The relationship between numbers of
migrating arterial S. vulgaris larvae and ELISA results is
illustrated in Figure 6. In the full dataset there was a
significant difference in the level of anti-SvSXP IgG(T)
antibodies, expressed as the PP-value, between S. vulgarisnegative horses (Group 0) and horses with migrating larvae
(groups 2,3 and 4). In the subset of horses seven months
and older there was a significant difference between the
same groups as well as a significant difference between
horses with no larvae but evidence of migratory tracts,
aneurysm or healing lesions (group 1), and horses with a
heavy infection (group 4).
A moderate positive correlation was found between the
number of S. vulgaris larvae in the CMA and branches
and the PP-value with an Rs of 0.5779 (0.433 – 0.693),
P <0.0001 in the data set including all horses. In the
data set including horses 7 months and older there was
a moderate positive correlation between the number of
S. vulgaris larvae in the CMA and branches and the
PP-value with an Rs of 0.5944 (0.44 – 0.714), P<0.0001.
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Figure 3 Western blot analysis of pre-immunisation guinea pig
serum (lanes A+C) and hyperimmune anti-rSvSXP guinea pig
serum (lanes B+D) against rSvSXP (A + B) and Strongylus vulgaris
larval excretory/secretory antigens (C + D). Hyperimmune serum
reacted against a similar sized molecule in both antigen mixtures while
pre-immunisation serum did not. The molecular weight markers are
shown to the left of each type of antigen.

Diagnostic accuracy

The relationship between sensitivity and specificity is listed
for the two datasets at different cut-off values (Table 2).
The diagnostic accuracy values expressed as sensitivity,
specificity, diagnostic odds ratio, as well as positive and
negative LR for each set of horses are shown for the optimal cut-off PP value in Table 3.

Discussion
The identification of the S. vulgaris SXP protein represents a promising advancement towards development of
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a diagnostic ELISA test capable of detecting the presence
of migrating S. vulgaris larvae in horses. In the present
study, four important criteria were met by this protein:
(i) the recombinant protein was bound by serum IgG(T)
primarily from horses harbouring infection or exhibiting
lesions associated with previous presence of S. vulgaris
larvae; (ii) the diagnostic odds ratio of the ELISA showed
that infection with migrating S. vulgaris larvae significantly increased the possibility of a positive test result;
(iii) other naturally occurring equine gastrointestinal
nematodes did not appear to interact with test results;
(iv) there is evidence of a semi-quantitative relationship
between infection intensity and ELISA results.
Similar proteins belonging to the SXP family are
expressed in other parasites infecting the horse, including cyathostomins and P. equorum. Cyathostomin SXPs
appear to be phylogenetically closely related to S.
vulgaris SXP, and cross-reactivity therefore remains a
potential problem for a diagnostic test (Figure 2). Ideally,
this could be tested with sera obtained from horses
mono-specifically infected with important equine nematodes. Unfortunately, despite many attempts no such
sera could be obtained from potential collaborators, and
this project did not have the resources to establish such
infections. It is still our ambition to establish such infections in the future, and these could be useful to further
refine and optimize diagnostic performance of the test.
The data generated in this study with horses being either
naturally or experimentally infected with major equine
helminth parasites. Although, this material illustrates
room for improvement of the diagnostic parameters of
the ELISA, it also illustrates the diagnostic potential.
The experimental infections with P. equorum and
cyathostomin parasites did not appear to dramatically
affect diagnostic performance (Table 1). Further, four
out of five of the defined subpopulations returned higher
sensitivity than specificity, which would not have been
the case if other parasites were stimulating a false ELISA
response. It should be borne in mind that sensitivity and
specificity for a diagnostic test depends largely on the
prevalence of the target organism. Thus, there will
always be different values in different study populations.
For this reason, it is considered more useful to evaluate
the diagnostic odds ratio (DOR) and the likelihood ratios
(LR) that are presented in Table 3. The DORs were high
and statistically significant, and the test is characterized
by a strong positive LR. High levels of cross-reactivity
with other species and stages would have led to more
false-positive test results, and, thus, a lower positive LR.
Taken together, rSvSXP represents a well-characterized
and better validated diagnostic antigen for S. vulgaris
diagnosis than any previously published attempt, and
there is good reason to continue developing and refining
diagnostic platforms utilizing this protein.
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Figure 4 Western blot with 233 ng recombinant SvSXP. Lanes 1–8 (box) were probed with serum from Strongylus vulgaris negative horse;
lanes 9–15 were probed with serum from S. vulgaris positive horses. HRP-conjugated goat anti-horse IgG(T) antibodies (Bethyl Laboratories, Inc.,
Montgomery, TX, USA) were used as secondary antibodies. The molecular weight is indicated to the left.

As the hyperimmune rat serum was raised against
adult S. vulgaris ES antigens and this was used to
perform the immunoscreening of the S. vulgaris larval
cDNA library, the protein must be expressed in both
larval and adult stages. Thus, it is possible that adult
stages in the intestine are also capable of affecting ELISA
measurements. However, previous work with surgically
implanted adult S. vulgaris worms in the caeca of
strongyle-naïve ponies revealed that IgG(T) antibodies
in these ponies did not differ from the non-specific
background reactivity in strongyle-naïve controls [30].

This suggests that the immune response and hence antibody production is primarily stimulated by the migrating
larvae and not the adult worms. Therefore, it remains
possible that the presence of the larvae in the blood
stream of the horse will allow a higher degree of exposure
of the SXP protein to the immune system and, consequently, to a higher degree of production of circulating
antibodies against it. More work is needed to investigate
this further, but the fair to good relationship found between
the number of arterial larvae and ELISA results does suggest that it is primarily the larvae that drive the test results.
Previously, total IgG(T) was associated with the presence of S. vulgaris larvae [49] and antigen-specific IgG(T)
antibodies have been shown to have immunodiagnostic
potential for diagnosing other gastrointestinal helminths
in horses [34,50,51]. In the present study, IgG(T) antibodies specific to rSvSXP also appeared to have a better
immunodiagnostic potential than other IgG subclasses
(Figures 5 and 6). The intra-assay % CV of mean OD450nm
values was within acceptable levels whereas the interTable 1 Prevalence of Strongylus vulgaris expressed as
prevalence of arterial lesions and seropositive horses

Figure 5 Boxplot showing optic density (OD) readings of the
enzyme-linked immunosorbent assay with antigen specific IgG
subclasses grouped by Strongylus vulgaris infection status. -: no
S. vulgaris larvae; +: S. vulgaris larvae present in the cranial
mesenteric artery or branches. The middle black line of the box is
the median and the range of the box is the inter quartile range
(IQR) giving the first and third IQR. The lower and upper lines are up
to 1.5 IQR away from the first and third quartile. Each square
represents the mean OD450nm reading from one serum sample for
each IgG subclass. Asterisks denote significant differences (p<0.05)
between uninfected and infected horses within each IgG subclass.

Group of horses

Prevalence Seropositive Se
of arterial prevalence
lesions

Sp

KY, naturally infected,
never treated herd (n=11)

100%

90.1%

90.9% 100%

KY, naturally infected,
treated herd (n=20)

10%

5%

50%

100%

TN, naturally infected (n=23) 73.9%

87.0%

94%

33%

TN, experimentally infected
with P. equorum (n=20)

70%

50%

64%

83%

TN, experimentally infected
with S. vulgaris and
Cyathostomins (n=28)

57.1%

39.3%

50%

75%

Sensitivity (Se) and specificity (Sp) is presented for each group of horses.
Case definition: A S. vulgaris positive horse has presence of larvae, migratory
tracts or healing lesions.
Cut-off value used: seropositive: PP-value above 8.75.
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Table 3 Diagnostic accuracy values with 95% confidence
intervals using the same cut-off value for two sets of horses:
A: all horses (n=102); B: horses 7 months or older (n=86)
Data set:

A

B

Cut-off value (PP)

8.75

13.47

Se

73.3% (60.3 – 83.9%)

65.5% (51.9 – 77.5%)

Sp

81.0% (65.9 – 91.4%)

82.1% (63.1 – 93.9%)

DOR

11.69 (4.48 – 30.5)

8.74 (2.89 – 26.48)

LR+

3.85 (2.03 – 7.32)

3.67 (1.62 – 8.30)

LR-

0.33 (0.21 – 0.51)

0.42 (0.28 – 0.62)

Cut-off values represent optimal sensitivity and specificity for each casedefinition. PP: percent of a positive control; Se: sensitivity; Sp: specificity; DOR:
diagnostic odds ratio; LR+: positive likelihood ratio; LR-: negative likelihood
ratio. The 95% confidence intervals are given in parentheses.

Figure 6 The relationship between serum anti-rSvSXP IgG(T)
antibody levels (expressed as percentage of a positive control
(PP)) and counts of migrating Strongylus vulgaris larvae
categorised by their number of larvae. a) All 102 horses in the data
set. b) The 86 horses in the data set aged 7 months and older. Group 0:
No larvae, migratory tracts nor evidence of previous infection (Figure 6a:
n=42; Figure 6b: n=28); group 1: Migratory tracts or evidence of previous
infection (n=16); group 2: 1–5 larvae (n=16); group 3: 6–25 larvae (n=17);
and group 4: >25 larvae (Figure 6a: n=11; Figure 6b: n=9). The middle
black line of the boxes is the median and the range of the box is the
inter quartile range (IQR) giving the first and third IQR. The lower and
upper lines are up to 1.5 IQR away from the first and third quartile.
Groups with different letters are significantly different (P-value < 0.05).

Table 2 Sensitivity and specificity at different cut-off
values of antibody responses against rSvSXP expressed as
percent of a positive control (PP), using two sets of horses:
A: all horses (n=102); B: horses 7 months or older (n=86)
Data set

A

B

PP cut-off

Se$

Sp$

Se

Sp

5

0.77

0.67

0.78

0.54

10

0.70

0.83

0.71

0.75

15

0.64

0.88

0.66

0.82

20

0.53

0.88

0.55

0.82

25

0.48

0.90

0.50

0.86

30

0.42

0.98

0.43

0.96

40

0.37

1

0.38

1

50

0.32

1

0.33

1

60

0.27

1

0.28

1

70

0.22

1

0.22

1

80

0.17

1

0.17

1

90

0.12

1

0.12

1

100

0.08

1

0.09

1

>100

0.05

1

0.02

AUC$
$

0.820

: Se: sensitivity; Sp: specificity; AUC: area under ROC curve.

1
0.783

assay % CV was substantially higher. However, the use of
the normalised PP value reduced the inter-assay % CV to
within acceptable levels, and we therefore recommend
reporting results of this assay as PP values.
The SvSXP protein belongs to the SXP/RAL-2 group of
proteins that appears to be nematode-specific with several
proteins described in animal and plant parasitic nematodes
[52-55]. The function of SXP/RAL-2 proteins is currently
unknown. The SXP proteins have been shown to be
potential vaccine candidates with reduced fecundity of
Ancylostoma caninum and degree of anaemia in vaccinated
dogs [56]. Additionally, SXP-proteins have been used for
serodiagnosis of human lymphatic filariasis [53,57] and
antibodies against BmSXP-1 and WbSXP-1 were used for
detection of circulating filarial antigens [58]. This further
supports the possibility that SvSXP possesses the essential
qualities required of a diagnostic antigen to be applied for
diagnosis of prepatent S. vulgaris infection in horses.
Although SvSXP was the only gene identified by
immunoscreening the cDNA library, the 26 randomly
amplified and sequenced cDNA clones from the quality
assessment step were all unique, suggesting that the library
is heterogeneous. It seems likely that the SvSXP protein is
highly immunogenic so that antiserum raised against ES
contains a high proportion of anti-SvSXP antibodies.
The semi-quantitative potential of the test is illustrated
in Figure 6. We performed a separate analysis in horses
older than seven months to evaluate if the ELISA would
perform better in this age group. Indeed, when comparing
Figure 6a and b there seems to be a better agreement
between the larval burden and the PP-value when foals
were excluded. This illustrates that younger foals can
harbour a large number of migrating larvae without
producing antibody titres, and more studies are needed to
explain this finding. However, it should be noted that the
AUC of the ROC curves and the diagnostic values calculated from both datasets are not significantly different from
each other. Thus, more studies are needed to identify a
possible minimum age for the use of the ELISA.
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The ELISA performed with a sensitivity and specificity
comparable to larval cultures carried out for detection of
S. vulgaris eggs [59], but has the potential for also
reflecting arterial larvae. The odds of a PP-value above
the cut-off among horses with migrating S. vulgaris
larvae, migratory tracts or evidence of previous infection
was 11.7 times higher than the odds of a similar ELISA
result among horses without migrating S. vulgaris larvae
or signs thereof. Moreover, a high PP-value indicates a
high number of migrating larvae (Figure 6). Even though
the sensitivity and specificity are moderate to good, the
false negative samples still comprise roughly a fifth of
the samples at the optimised cut-off value. For a rare,
potentially life-threatening disease the optimal assay
would be a highly sensitive test, especially when used at
an individual level. This will, however, lead to treatment
of 19% of horses with no current infection with S.
vulgaris. If the test is to function as a screening tool on
a herd level it requires a high specificity and the resulting
lowered sensitivity in this assay can be counteracted by
increasing the number of horses sampled. Table 2 can be
used to optimise the interpretation of the test-result on
both an individual level and a herd level.

Conclusion
In conclusion, we have identified a promising candidate
antigen for diagnosing S. vulgaris infection at the
prepatent stage. Our work illustrates that SvSXP is highly
immunogenic and that IgG(T) antibodies specific for
rSvSXP had the highest diagnostic potential both in WB
analysis as well as in an indirect ELISA.
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